Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Raquel Vivet-Noguer, Malcy Tarin, Sergio Román-Román, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 1019-1019
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Uveal melanoma
Martine J. Jager, Carol L. Shields, Colleen M. Cebulla, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 596
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 20
Current Molecular Markers of Melanoma and Treatment Targets
Kevin Yang, Allen S. W. Oak, Radomir M. Slominski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3535-3535
Open Access | Times Cited: 69
Update on uveal melanoma: Translational research from biology to clinical practice (Review)
Miguel Á. Ortega, Oscar Fraile‐Martínez, Natalio García‐Honduvilla, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 6, pp. 1262-1279
Open Access | Times Cited: 50
Uveal melanoma: progress in molecular biology and therapeutics
Yongyun Li, Jiahao Shi, Jie Yang, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 49
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review
Mario Damiano Toro, Lucia Gozzo, Luciano Tracia, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1311-1311
Open Access | Times Cited: 28
A Review and Comparison of Immune-Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
Benyamin Alam, Amir Reza Akbari, Ahmed Ageed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 885-885
Open Access
Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
Jackson R. Richards, Jae Hyuk Yoo, Donghan Shin, et al.
Pigment Cell & Melanoma Research (2019) Vol. 33, Iss. 2, pp. 264-278
Open Access | Times Cited: 30
Genetic Landscape and Emerging Therapies in Uveal Melanoma
Rino S. Seedor, Marlana Orloff, Takami Sato
Cancers (2021) Vol. 13, Iss. 21, pp. 5503-5503
Open Access | Times Cited: 24
MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators
Karen Aughton, Helen Kalirai, Sarah E. Coupland
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5648-5648
Open Access | Times Cited: 26
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma
Didier Decaudin, Estelle Frisch Dit Leitz, Fariba Némati, et al.
European Journal of Cancer (2020) Vol. 126, pp. 93-103
Open Access | Times Cited: 24
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
Malcy Tarin, Fariba Némati, Didier Decaudin, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2280-2280
Open Access | Times Cited: 9
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations
Liu Hon, Zhou Run‐hua, Jingxuan Pan, et al.
Pigment Cell & Melanoma Research (2024) Vol. 37, Iss. 3, pp. 411-425
Closed Access | Times Cited: 3
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
Sara Rezzola, Roberto Ronca, Alessandra Loda, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1305-1305
Open Access | Times Cited: 24
New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma
Alexander Z. Wei, Ashray Maniar, Richard D. Carvajal
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1819-1826
Closed Access | Times Cited: 14
Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma
Ge Yang, Junjie Deng, Jianzheng Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 8, pp. 3326-3340
Open Access | Times Cited: 14
Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma
Chun Yang, Rui Wang, Pierre Hardy
Cancers (2021) Vol. 13, Iss. 20, pp. 5192-5192
Open Access | Times Cited: 16
Pathological and Molecular Diagnosis of Uveal Melanoma
Mihai Adrian Păsărică, Paul Filip Curcă, Christiana Diana Maria Dragosloveanu, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 958-958
Open Access | Times Cited: 2
Emerging roles of microRNAs and their implications in uveal melanoma
Chun Yang, Yuejiao Wang, Pierre Hardy
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 2, pp. 545-559
Open Access | Times Cited: 17
Uveal melanoma modeling in mice and zebrafish
Quincy C. C. van den Bosch, Annelies de Klein, Robert M. Verdijk, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189055-189055
Open Access | Times Cited: 4
Novel Prognostic Factor for Uveal Melanoma: Bioinformatics Analysis of Three Independent Cohorts
Suji Choi, Mihyang Ha, Jung Sub Lee, et al.
Anticancer Research (2020) Vol. 40, Iss. 7, pp. 3839-3846
Open Access | Times Cited: 11
Glycolysis Dependency as a Hallmark of SF3B1-Mutated Cells
Raquel Vivet-Noguer, Malcy Tarin, Christine Canbezdi, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2113-2113
Open Access | Times Cited: 7
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study
Serge Leyvraz, Frank Konietschke, Caroline Anna Peuker, et al.
European Journal of Cancer (2022) Vol. 169, pp. 146-155
Closed Access | Times Cited: 6
A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study
Meng Lv, Xinhua Yan, Yuanxing Tu
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies
Jana Jakubechova, Božena Smolková, Alena Furdová, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12957-12957
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top